Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 10, 2019

SELL
$166.7 - $195.41 $810,495 - $950,083
-4,862 Closed
0 $0
Q1 2019

May 01, 2019

SELL
$180.87 - $203.88 $9,405 - $10,601
-52 Reduced 1.06%
4,862 $924,000
Q4 2018

Feb 12, 2019

BUY
$178.4 - $208.25 $3,568 - $4,165
20 Added 0.41%
4,914 $957,000
Q3 2018

Oct 10, 2018

SELL
$185.29 - $208.89 $167,131 - $188,418
-902 Reduced 15.56%
4,894 $998,000
Q1 2018

Apr 17, 2018

SELL
$169.43 - $198.0 $15,079 - $17,622
-89 Reduced 1.51%
5,796 $988,000
Q4 2017

Jan 16, 2018

BUY
$168.79 - $188.59 $25,318 - $28,288
150 Added 2.62%
5,885 $1.02 Million
Q3 2017

Oct 23, 2017

BUY
$167.29 - $191.0 $959,408 - $1.1 Million
5,735
5,735 $1.07 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Oliver Luxxe Assets LLC Portfolio

Follow Oliver Luxxe Assets LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oliver Luxxe Assets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oliver Luxxe Assets LLC with notifications on news.